The University of Chicago Header Logo

Connection

David Grdina to Mice

This is a "connection" page, showing publications David Grdina has written about Mice.
Connection Strength

0.923
  1. Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions. Int J Radiat Biol. 2017 07; 93(7):665-675.
    View in: PubMed
    Score: 0.056
  2. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity. Free Radic Biol Med. 2016 10; 99:110-119.
    View in: PubMed
    Score: 0.054
  3. NF?B and Survivin-Mediated Radio-Adaptive Response. Radiat Res. 2015 Apr; 183(4):391-7.
    View in: PubMed
    Score: 0.049
  4. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 2014 May; 181(5):464-70.
    View in: PubMed
    Score: 0.046
  5. A survivin-associated adaptive response in radiation therapy. Cancer Res. 2013 Jul 15; 73(14):4418-28.
    View in: PubMed
    Score: 0.043
  6. A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res. 2013 Feb; 179(2):115-24.
    View in: PubMed
    Score: 0.042
  7. SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine. Free Radic Biol Med. 2011 Nov 15; 51(10):1918-25.
    View in: PubMed
    Score: 0.038
  8. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):886-96.
    View in: PubMed
    Score: 0.032
  9. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine. Radiat Res. 2008 May; 169(5):495-505.
    View in: PubMed
    Score: 0.030
  10. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res. 2004 Nov; 162(5):536-46.
    View in: PubMed
    Score: 0.024
  11. Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. Semin Oncol. 2002 Dec; 29(6 Suppl 19):22-8.
    View in: PubMed
    Score: 0.021
  12. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res. 2002 Jul; 158(1):101-9.
    View in: PubMed
    Score: 0.020
  13. Inhibition of spontaneous metastases formation by amifostine. Int J Cancer. 2002 Jan 10; 97(2):135-41.
    View in: PubMed
    Score: 0.020
  14. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
    View in: PubMed
    Score: 0.018
  15. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000; 16(4):237-79.
    View in: PubMed
    Score: 0.017
  16. Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide. Semin Oncol. 1999 Apr; 26(2 Suppl 7):22-7.
    View in: PubMed
    Score: 0.016
  17. Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 Cells. Radiat Res. 2017 07; 188(1):66-74.
    View in: PubMed
    Score: 0.014
  18. Antimutagenic effects of amifostine: clinical implications. Semin Oncol. 1996 Aug; 23(4 Suppl 8):53-7.
    View in: PubMed
    Score: 0.013
  19. Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Res. 1995 Nov 01; 55(21):4788-92.
    View in: PubMed
    Score: 0.013
  20. CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection. Free Radic Biol Med. 2015 Apr; 81:77-87.
    View in: PubMed
    Score: 0.012
  21. Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent. Cell Biol Toxicol. 2014 Feb; 30(1):55-66.
    View in: PubMed
    Score: 0.011
  22. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45.
    View in: PubMed
    Score: 0.011
  23. Induction of hprt mutations in mice after exposure to fission-spectrum neutrons or 60Co gamma rays. Radiat Res. 1993 Nov; 136(2):289-92.
    View in: PubMed
    Score: 0.011
  24. Comparing radiation toxicities across species: an examination of radiation effects in Mus musculus and Peromyscus leucopus. Int J Radiat Biol. 2013 Jun; 89(6):391-400.
    View in: PubMed
    Score: 0.011
  25. The effects of radiation and dose-fractionation on cancer and non-tumor disease development. Int J Environ Res Public Health. 2012 Dec 18; 9(12):4688-703.
    View in: PubMed
    Score: 0.010
  26. CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol. 2013 Jun; 5(3):166-75.
    View in: PubMed
    Score: 0.010
  27. The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation. Carcinogenesis. 1992 May; 13(5):811-4.
    View in: PubMed
    Score: 0.010
  28. In vivo protection by the aminothiol WR-2721 against neutron-induced carcinogenesis. Int J Radiat Biol. 1992 May; 61(5):567-76.
    View in: PubMed
    Score: 0.010
  29. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice. Int J Radiat Biol. 1992 Mar; 61(3):387-92.
    View in: PubMed
    Score: 0.010
  30. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons. Adv Space Res. 1992; 12(2-3):257-63.
    View in: PubMed
    Score: 0.010
  31. Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury. Crit Care Med. 2011 Dec; 39(12):2711-21.
    View in: PubMed
    Score: 0.010
  32. Misoprostol, a PGE1 analog, protects mice from fission-neutron injury. Radiat Res. 1991 Oct; 128(1 Suppl):S12-7.
    View in: PubMed
    Score: 0.010
  33. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons. Radiat Res. 1991 Oct; 128(1 Suppl):S124-7.
    View in: PubMed
    Score: 0.010
  34. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1991 Aug 15; 51(16):4125-30.
    View in: PubMed
    Score: 0.010
  35. Pathological effects of the radiation protector WR-151327 in mice. Radiat Res. 1990 Oct; 124(1):79-84.
    View in: PubMed
    Score: 0.009
  36. Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma. Clin Exp Metastasis. 1989 Mar-Apr; 7(2):243-50.
    View in: PubMed
    Score: 0.008
  37. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J. 2009 Mar; 33(3):612-24.
    View in: PubMed
    Score: 0.008
  38. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. Int J Radiat Biol. 2008 Aug; 84(8):623-34.
    View in: PubMed
    Score: 0.008
  39. Modification of radiation response in mice by fractionated extracts of Panax ginseng. Radiat Res. 1987 Oct; 112(1):156-63.
    View in: PubMed
    Score: 0.007
  40. Radiation-induced DNA single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Jul; 52(1):67-76.
    View in: PubMed
    Score: 0.007
  41. 2-[(Aminopropyl)amino]ethanethiol (WR1065) is anti-neoplastic and anti-mutagenic when given during 60Co gamma-ray irradiation. Carcinogenesis. 1986 Apr; 7(4):665-8.
    View in: PubMed
    Score: 0.007
  42. Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules. Clin Exp Metastasis. 1984 Jul-Sep; 2(3):223-33.
    View in: PubMed
    Score: 0.006
  43. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. Int J Radiat Oncol Biol Phys. 1984 Mar; 10(3):379-83.
    View in: PubMed
    Score: 0.006
  44. Density gradient centrifugation of tumor cells from needle biopsies and their respective source tumors: a comparison of density distributions. Experientia. 1983 Aug 15; 39(8):916-7.
    View in: PubMed
    Score: 0.005
  45. Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules. Br J Cancer. 1983 Aug; 48(2):279-87.
    View in: PubMed
    Score: 0.005
  46. Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivo. Biochim Biophys Acta. 2003 Mar 20; 1637(2):151-5.
    View in: PubMed
    Score: 0.005
  47. Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy. Clin Exp Metastasis. 1983 Jan-Mar; 1(1):71-81.
    View in: PubMed
    Score: 0.005
  48. Lung tumorigenic response of strain A mice exposed to hypoxic cell sensitizers alone and in combination with gamma-radiation. Cancer Res. 1983 Jan; 43(1):146-9.
    View in: PubMed
    Score: 0.005
  49. Kinetic heterogeneity in density-separated murine fibrosarcoma subpopulations. Cancer Res. 1982 Dec; 42(12):4999-5003.
    View in: PubMed
    Score: 0.005
  50. Cyclic-radiation response of murine fibrosarcoma cells grown as pulmonary nodules. Int J Radiat Oncol Biol Phys. 1982 Oct; 8(10):1727-34.
    View in: PubMed
    Score: 0.005
  51. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules. Br J Cancer. 1982 Mar; 45(3):438-46.
    View in: PubMed
    Score: 0.005
  52. Density centrifugation of murine fibrosarcoma cells following in situ labelling with tritiated thymidine. Cell Tissue Kinet. 1981 Nov; 14(6):589-600.
    View in: PubMed
    Score: 0.005
  53. In vivo cell cycle phase-preferential killing of murine fibrosarcoma cells by cisplatin. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):845-51.
    View in: PubMed
    Score: 0.005
  54. Velocity sedimentation of tumor cells: a comparison of methods. Experientia. 1981 May 15; 37(5):501-2.
    View in: PubMed
    Score: 0.005
  55. Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. Br J Cancer. 1980 Nov; 42(5):677-83.
    View in: PubMed
    Score: 0.005
  56. Separation of solid tumor cell populations. Antibiot Chemother (1971). 1980; 28:137-41.
    View in: PubMed
    Score: 0.004
  57. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Cancer Clin Trials. 1980; 3(2):149-54.
    View in: PubMed
    Score: 0.004
  58. Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res. 1999 Nov 15; 59(22):5836-41.
    View in: PubMed
    Score: 0.004
  59. Cytotoxic effect of adriamycin in vivo on synchronized murine fibrosarcoma cells. Int J Radiat Oncol Biol Phys. 1979 Aug; 5(8):1305-8.
    View in: PubMed
    Score: 0.004
  60. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma cells synchronized by centrifugal elutriation. Br J Cancer. 1979 Feb; 39(2):152-8.
    View in: PubMed
    Score: 0.004
  61. Separation of cells from a murine fibrosarcoma on the basis of size. I. Relationship between cell size and age as modified by growth in vivo or in vitro. J Natl Cancer Inst. 1978 Jul; 61(1):209-14.
    View in: PubMed
    Score: 0.004
  62. Separation of cells from a murine fibrosarcoma on the basis of size. II. Differential effects of cell size and age on lung retention and colony formation in normal and preconditioned mice. J Natl Cancer Inst. 1978 Jul; 61(1):215-20.
    View in: PubMed
    Score: 0.004
  63. Response of selected tumour cell populations separated from a fibrosarcoma following irradiation in situ with fast neutrons. Br J Radiol. 1978 Apr; 51(604):291-301.
    View in: PubMed
    Score: 0.004
  64. Relevance of density, size and DNA content of tumour cells to the lung colony assay. Br J Cancer. 1977 Dec; 36(6):659-69.
    View in: PubMed
    Score: 0.004
  65. Regulation of thymus PCNA expression is altered in radiation-sensitive wasted mice. Carcinogenesis. 1996 Nov; 17(11):2357-65.
    View in: PubMed
    Score: 0.003
  66. Radiation response of cell populations irradiated in situ and separated from a fibrosarcoma. Radiat Res. 1976 Jun; 66(3):634-43.
    View in: PubMed
    Score: 0.003
  67. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res. 1996 May; 145(5):610-8.
    View in: PubMed
    Score: 0.003
  68. Radiation response of clonogenic cell populations separated from fibrosarcoma. Radiat Res. 1975 Sep; 63(3):483-93.
    View in: PubMed
    Score: 0.003
  69. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):13047-51.
    View in: PubMed
    Score: 0.003
  70. Transformation of human epidermal keratinocytes with fission neutrons. Carcinogenesis. 1994 Dec; 15(12):2867-73.
    View in: PubMed
    Score: 0.003
  71. Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):867-72.
    View in: PubMed
    Score: 0.003
  72. Separation of cells from a fibrosarcoma in renografin density gradients. J Natl Cancer Inst. 1974 Jan; 52(1):253-7.
    View in: PubMed
    Score: 0.003
  73. Characterization of a human ovarian carcinoma. Anal Quant Cytol Histol. 1989 Oct; 11(5):324-30.
    View in: PubMed
    Score: 0.002
  74. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
    View in: PubMed
    Score: 0.002
  75. The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
    View in: PubMed
    Score: 0.002
  76. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327. Radiat Res. 1986 May; 106(2):224-33.
    View in: PubMed
    Score: 0.002
  77. Response of fibrosarcoma cell subpopulations to small doses of radiation delivered in situ. Int J Radiat Oncol Biol Phys. 1983 Feb; 9(2):217-20.
    View in: PubMed
    Score: 0.001
  78. Radiation sensitivity of murine fibrosarcoma cells separated by centrifugal elutriation. Radiat Res. 1979 Nov; 80(2):389-97.
    View in: PubMed
    Score: 0.001
  79. Density gradient centrifugation of cells separated from multicellular tumor spheroids. Experientia. 1979 Jun 15; 35(6):815-7.
    View in: PubMed
    Score: 0.001
  80. Separation of cells from mouse solid tumors by centrifugal elutriation. Cancer Res. 1977 Dec; 37(12):4291-6.
    View in: PubMed
    Score: 0.001
  81. Cell cycle dependency of metastatic lung colony formation. Cancer Res. 1977 Oct; 37(10):3690-3.
    View in: PubMed
    Score: 0.001
  82. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1975 Sep; 55(3):589-96.
    View in: PubMed
    Score: 0.001
  83. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum. J Natl Cancer Inst. 1975 Apr; 54(4):895-902.
    View in: PubMed
    Score: 0.001
  84. Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1974 Jun; 52(6):1839-42.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.